Rose Sharon Shabet - Net Worth and Insider Trading
Rose Sharon Shabet Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rose Sharon Shabet owns 19 companies in total, including Inhibrx Inc (INBX) , APi Group Corp (APG) , and Zentalis Pharmaceuticals Inc (ZNTL) among others .
Click here to see the complete history of Rose Sharon Shabet’s form 4 insider trades.
Insider Ownership Summary of Rose Sharon Shabet
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INBX | Inhibrx Inc | 2023-08-28 | 10 percent owner |
| APG | APi Group Corp | 2020-04-28 | 10 percent owner |
| ZNTL | Zentalis Pharmaceuticals Inc | 2020-04-03 | 10 percent owner |
 | | 2019-06-26 | 10 percent owner |
| | 2017-07-01 | 10 percent owner |
| | 2017-07-01 | 10 percent owner |
| | 2017-07-01 | 10 percent owner |
| | 2019-07-10 | other: Former 10% Owner |
| | 2019-06-27 | 10 percent owner |
| | 2022-03-18 | 10 percent owner |
| | 2021-10-01 | 10 percent owner |
| | 2023-05-09 | 10 percent owner |
| | 2022-01-06 | 10 percent owner |
| | 2022-11-15 | 10 percent owner |
| | 2022-03-02 | 10 percent owner |
| | 2021-05-26 | 10 percent owner |
| | 2022-11-01 | 10 percent owner |
| | 2022-11-01 | 10 percent owner |
| | 2023-09-14 | 10 percent owner |
Rose Sharon Shabet Trading Performance
Rose Sharon Shabet Ownership Network
Rose Sharon Shabet Owned Company Details
What does Inhibrx Inc do?
Who are the key executives at Inhibrx Inc?
Rose Sharon Shabet is the 10 percent owner of Inhibrx Inc. Other key executives at Inhibrx Inc include director & 10 percent owner & Chief Scientific Officer Brendan P. Eckelman , 10 percent owner Ole Andreas Halvorsen , and 10 percent owner Viking Global Opportunities Parent Gp Llc .
Inhibrx Inc (INBX) Insider Trades Summary
Over the past 18 months, Rose Sharon Shabet made no insider transaction in Inhibrx Inc (INBX). Other recent insider transactions involving Inhibrx Inc (INBX) include a net purchase of 511,627 shares made by Viking Global Investors Lp , and a net sale of 300,000 shares made by Brendan P. Eckelman .
In summary, during the past 3 months, insiders sold 0 shares of Inhibrx Inc (INBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 300,000 shares of Inhibrx Inc (INBX) were sold and 511,627 shares were bought by its insiders, resulting in a net purchase of 211,627 shares.
Inhibrx Inc (INBX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inhibrx Inc Insider Transactions
- Download to Excel(.xls)
What does APi Group Corp do?
Who are the key executives at APi Group Corp?
Rose Sharon Shabet is the 10 percent owner of APi Group Corp. Other key executives at APi Group Corp include See Remarks Louis Lambert , 10 percent owner Viking Global Investors Lp , and Chief Financial Officer Kevin Krumm .
APi Group Corp (APG) Insider Trades Summary
Over the past 18 months, Rose Sharon Shabet made no insider transaction in APi Group Corp (APG). Other recent insider transactions involving APi Group Corp (APG) include a net sale of 22,980,798 shares made by Viking Global Investors Lp , a net sale of 950,000 shares made by Ashken Ian G H , and a net sale of 875,000 shares made by James E Lillie .
In summary, during the past 3 months, insiders sold 947,012 shares of APi Group Corp (APG) in total and bought 0 shares, with a net sale of 947,012 shares. During the past 18 months, 31,340,613 shares of APi Group Corp (APG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 31,340,613 shares.
APi Group Corp (APG)'s detailed insider trading history can be found in Insider Trading Tracker table.
APi Group Corp Insider Transactions
- Download to Excel(.xls)
What does Zentalis Pharmaceuticals Inc do?
Who are the key executives at Zentalis Pharmaceuticals Inc?
Rose Sharon Shabet is the 10 percent owner of Zentalis Pharmaceuticals Inc. Other key executives at Zentalis Pharmaceuticals Inc include Chief Financial Officer Melissa B, Epperly , General Counsel Andrea Paul , and Chief Medical Officer Carrie Brownstein .
Zentalis Pharmaceuticals Inc (ZNTL) Insider Trades Summary
Over the past 18 months, Rose Sharon Shabet made no insider transaction in Zentalis Pharmaceuticals Inc (ZNTL). Other recent insider transactions involving Zentalis Pharmaceuticals Inc (ZNTL) include a net sale of 50,090 shares made by Cam Gallagher , a net sale of 16,724 shares made by Melissa B, Epperly , and a net sale of 86,068 shares made by Kevin D. Bunker .
In summary, during the past 3 months, insiders sold 0 shares of Zentalis Pharmaceuticals Inc (ZNTL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 176,761 shares of Zentalis Pharmaceuticals Inc (ZNTL) were sold and 22,000 shares were bought by its insiders, resulting in a net sale of 154,761 shares.
Zentalis Pharmaceuticals Inc (ZNTL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zentalis Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Adaptive Biotechnologies Corp do?
Who are the key executives at Adaptive Biotechnologies Corp?
Rose Sharon Shabet is the 10 percent owner of Adaptive Biotechnologies Corp. Other key executives at Adaptive Biotechnologies Corp include SVP and General Counsel Stacy L Taylor , Chief Financial Officer Tycho Peterson , and Principal Accounting Officer Kyle Piskel .
Adaptive Biotechnologies Corp (ADPT) Insider Trades Summary
Over the past 18 months, Rose Sharon Shabet made no insider transaction in Adaptive Biotechnologies Corp (ADPT). Other recent insider transactions involving Adaptive Biotechnologies Corp (ADPT) include a net sale of 258,417 shares made by Tycho Peterson , a net sale of 40,303 shares made by Stacy L Taylor , and a net sale of 7,986 shares made by Kyle Piskel .
In summary, during the past 3 months, insiders sold 26,922 shares of Adaptive Biotechnologies Corp (ADPT) in total and bought 0 shares, with a net sale of 26,922 shares. During the past 18 months, 473,198 shares of Adaptive Biotechnologies Corp (ADPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 473,198 shares.
Adaptive Biotechnologies Corp (ADPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptive Biotechnologies Corp Insider Transactions
- Download to Excel(.xls)
What does Arbutus Biopharma Corp do?
Who are the key executives at Arbutus Biopharma Corp?
Rose Sharon Shabet is the 10 percent owner of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Scientific Officer Michael J. Sofia .
Arbutus Biopharma Corp (ABUS) Insider Trades Summary
Over the past 18 months, Rose Sharon Shabet made no insider transaction in Arbutus Biopharma Corp (ABUS). Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .
In summary, during the past 3 months, insiders sold 8,846 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 8,846 shares. During the past 18 months, 42,943 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,943 shares.
Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arbutus Biopharma Corp Insider Transactions
- Download to Excel(.xls)
What does Sio Gene Therapies Inc do?
Who are the key executives at Sio Gene Therapies Inc?
Rose Sharon Shabet is the 10 percent owner of Sio Gene Therapies Inc. Other key executives at Sio Gene Therapies Inc include Chief Commercial Officer Parag V Meswani , Chief Executive Officer Pavan Cheruvu , and 10 percent owner Roivant Sciences Ltd. .
Sio Gene Therapies Inc (SIOX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sio Gene Therapies Inc (SIOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sio Gene Therapies Inc (SIOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sio Gene Therapies Inc (SIOX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sio Gene Therapies Inc Insider Transactions
- Download to Excel(.xls)
What does Myovant Sciences Ltd do?
Who are the key executives at Myovant Sciences Ltd?
Rose Sharon Shabet is the 10 percent owner of Myovant Sciences Ltd. Other key executives at Myovant Sciences Ltd include 10 percent owner Sumitomo Chemical Co., Ltd. , Chief Commercial Officer Lauren Merendino , and General Counsel & Corp. Secy. Matthew Lang .
Myovant Sciences Ltd (MYOV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Myovant Sciences Ltd (MYOV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Myovant Sciences Ltd (MYOV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Myovant Sciences Ltd (MYOV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Myovant Sciences Ltd Insider Transactions
- Download to Excel(.xls)
What does Urovant Sciences Ltd do?
Who are the key executives at Urovant Sciences Ltd?
Rose Sharon Shabet is the other: Former 10% Owner of Urovant Sciences Ltd. Other key executives at Urovant Sciences Ltd include SVP & Commercial & USI Walt Johnston , CMO/Urovant Sciences & Inc. Haag-molkenteller Cornelia , and PFO;CFO/Urovant Sciences & Inc. Ajay Bansal .
Urovant Sciences Ltd (UROV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Urovant Sciences Ltd (UROV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Urovant Sciences Ltd (UROV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Urovant Sciences Ltd (UROV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Urovant Sciences Ltd Insider Transactions
- Download to Excel(.xls)
What does BridgeBio Pharma Inc do?
Who are the key executives at BridgeBio Pharma Inc?
Rose Sharon Shabet is the 10 percent owner of BridgeBio Pharma Inc. Other key executives at BridgeBio Pharma Inc include 10 percent owner Kkr Genetic Disorder L.p. , director & See Remarks Neil Kumar , and See Remarks Brian C Stephenson .
BridgeBio Pharma Inc (BBIO) Insider Trades Summary
Over the past 18 months, Rose Sharon Shabet made no insider transaction in BridgeBio Pharma Inc (BBIO). Other recent insider transactions involving BridgeBio Pharma Inc (BBIO) include a net sale of 422,045 shares made by Neil Kumar , a net sale of 194,376 shares made by Brian C Stephenson , and a net sale of 12,000 shares made by Randal W Scott .
In summary, during the past 3 months, insiders sold 5,831,544 shares of BridgeBio Pharma Inc (BBIO) in total and bought 0 shares, with a net sale of 5,831,544 shares. During the past 18 months, 8,037,166 shares of BridgeBio Pharma Inc (BBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,037,166 shares.
BridgeBio Pharma Inc (BBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
BridgeBio Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does PROCEPT BioRobotics Corp do?
Who are the key executives at PROCEPT BioRobotics Corp?
Rose Sharon Shabet is the 10 percent owner of PROCEPT BioRobotics Corp. Other key executives at PROCEPT BioRobotics Corp include Senior VP & CFO Kevin Waters , director & 10 percent owner Antal Rohit Desai , and SVP & GEN COUNSEL & CORP. SEC. Alaleh Nouri .
PROCEPT BioRobotics Corp (PRCT) Insider Trades Summary
Over the past 18 months, Rose Sharon Shabet made no insider transaction in PROCEPT BioRobotics Corp (PRCT). Other recent insider transactions involving PROCEPT BioRobotics Corp (PRCT) include a net sale of 207,880 shares made by Kevin Waters , a net sale of 108,621 shares made by Alaleh Nouri , and a net sale of 49,979 shares made by Hisham Shiblaq .
In summary, during the past 3 months, insiders sold 247,222 shares of PROCEPT BioRobotics Corp (PRCT) in total and bought 0 shares, with a net sale of 247,222 shares. During the past 18 months, 747,272 shares of PROCEPT BioRobotics Corp (PRCT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 747,272 shares.
PROCEPT BioRobotics Corp (PRCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
PROCEPT BioRobotics Corp Insider Transactions
- Download to Excel(.xls)
What does Roivant Sciences Ltd do?
Who are the key executives at Roivant Sciences Ltd?
Rose Sharon Shabet is the 10 percent owner of Roivant Sciences Ltd. Other key executives at Roivant Sciences Ltd include President & COO Eric Venker , 10 percent owner Svf Investments (uk) Ltd , and 10 percent owner & other: Director by Deputization Qvt Financial Lp .
Roivant Sciences Ltd (ROIV) Insider Trades Summary
Over the past 18 months, Rose Sharon Shabet made no insider transaction in Roivant Sciences Ltd (ROIV). Other recent insider transactions involving Roivant Sciences Ltd (ROIV) include a net sale of 3,996,950 shares made by Eric Venker , a net sale of 458,143 shares made by Rakhi Kumar , and a net sale of 15,116,277 shares made by Sumitomo Chemical Co., Ltd. .
In summary, during the past 3 months, insiders sold 0 shares of Roivant Sciences Ltd (ROIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 82,467,514 shares of Roivant Sciences Ltd (ROIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 82,467,514 shares.
Roivant Sciences Ltd (ROIV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Roivant Sciences Ltd Insider Transactions
- Download to Excel(.xls)
What does 4D Molecular Therapeutics Inc do?
Who are the key executives at 4D Molecular Therapeutics Inc?
Rose Sharon Shabet is the 10 percent owner of 4D Molecular Therapeutics Inc. Other key executives at 4D Molecular Therapeutics Inc include Chief Legal and HR Officer Scott Bizily , director & Chief Executive Officer David Kirn , and Chief Medical Officer Robert Young Kim .
4D Molecular Therapeutics Inc (FDMT) Insider Trades Summary
Over the past 18 months, Rose Sharon Shabet made no insider transaction in 4D Molecular Therapeutics Inc (FDMT). Other recent insider transactions involving 4D Molecular Therapeutics Inc (FDMT) include a net sale of 43,633 shares made by Scott Bizily , a net sale of 225,853 shares made by David Kirn , and a net purchase of 310,000 shares made by Viking Global Investors Lp .
In summary, during the past 3 months, insiders sold 34,847 shares of 4D Molecular Therapeutics Inc (FDMT) in total and bought 0 shares, with a net sale of 34,847 shares. During the past 18 months, 839,038 shares of 4D Molecular Therapeutics Inc (FDMT) were sold and 850,000 shares were bought by its insiders, resulting in a net purchase of 10,962 shares.
4D Molecular Therapeutics Inc (FDMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
4D Molecular Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Amylyx Pharmaceuticals Inc do?
Who are the key executives at Amylyx Pharmaceuticals Inc?
Rose Sharon Shabet is the 10 percent owner of Amylyx Pharmaceuticals Inc. Other key executives at Amylyx Pharmaceuticals Inc include Chief Financial Officer James M Frates , Chief Legal Officer Gina Mazzariello , and director & Co-Chief Executive Officer Joshua B Cohen .
Amylyx Pharmaceuticals Inc (AMLX) Insider Trades Summary
Over the past 18 months, Rose Sharon Shabet made no insider transaction in Amylyx Pharmaceuticals Inc (AMLX). Other recent insider transactions involving Amylyx Pharmaceuticals Inc (AMLX) include a net sale of 20,997 shares made by Gina Mazzariello , a net purchase of 2,992 shares made by James M Frates , and a net sale of 253,460 shares made by Morningside Venture Investments Ltd .
In summary, during the past 3 months, insiders sold 0 shares of Amylyx Pharmaceuticals Inc (AMLX) in total and bought 190,000 shares, with a net purchase of 190,000 shares. During the past 18 months, 395,773 shares of Amylyx Pharmaceuticals Inc (AMLX) were sold and 199,000 shares were bought by its insiders, resulting in a net sale of 196,773 shares.
Amylyx Pharmaceuticals Inc (AMLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amylyx Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Rallybio Corp do?
Who are the key executives at Rallybio Corp?
Rose Sharon Shabet is the 10 percent owner of Rallybio Corp. Other key executives at Rallybio Corp include 10 percent owner 5am Partners V, Llc , director & 10 percent owner Kush Parmar , and See Remarks Jonathan I Lieber .
Rallybio Corp (RLYB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Rallybio Corp (RLYB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rallybio Corp (RLYB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Rallybio Corp (RLYB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rallybio Corp Insider Transactions
- Download to Excel(.xls)
What does Ginkgo Bioworks Holdings Inc do?
Who are the key executives at Ginkgo Bioworks Holdings Inc?
Rose Sharon Shabet is the 10 percent owner of Ginkgo Bioworks Holdings Inc. Other key executives at Ginkgo Bioworks Holdings Inc include Chief Accounting Officer Steven P. Coen , Chief Financial Officer Mark E. Dmytruk , and director & CEO & Chairman Harry Sloan .
Ginkgo Bioworks Holdings Inc (DNA) Insider Trades Summary
Over the past 18 months, Rose Sharon Shabet made no insider transaction in Ginkgo Bioworks Holdings Inc (DNA). Other recent insider transactions involving Ginkgo Bioworks Holdings Inc (DNA) include a net sale of 8,200,000 shares made by Jason R Kelly , a net sale of 3,012,000 shares made by Reshma P. Shetty , and a net sale of 3,012,000 shares made by Barry Canton .
In summary, during the past 3 months, insiders sold 5,057 shares of Ginkgo Bioworks Holdings Inc (DNA) in total and bought 0 shares, with a net sale of 5,057 shares. During the past 18 months, 438,783 shares of Ginkgo Bioworks Holdings Inc (DNA) were sold and 41,815 shares were bought by its insiders, resulting in a net sale of 396,968 shares.
Ginkgo Bioworks Holdings Inc (DNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ginkgo Bioworks Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does FIGS Inc do?
Who are the key executives at FIGS Inc?
Rose Sharon Shabet is the 10 percent owner of FIGS Inc. Other key executives at FIGS Inc include director & 10 percent owner & Co-Chief Executive Officer Heather L. Hasson , Chief Financial Officer Daniella Turenshine , and director & 10 percent owner & Co-Chief Executive Officer Catherine Eva Spear .
FIGS Inc (FIGS) Insider Trades Summary
Over the past 18 months, Rose Sharon Shabet made no insider transaction in FIGS Inc (FIGS). Other recent insider transactions involving FIGS Inc (FIGS) include a net sale of 1,455,494 shares made by Heather L. Hasson , a net sale of 122,172 shares made by Daniella Turenshine , and a net sale of 1,478 shares made by .
In summary, during the past 3 months, insiders sold 44,591 shares of FIGS Inc (FIGS) in total and bought 0 shares, with a net sale of 44,591 shares. During the past 18 months, 1,579,144 shares of FIGS Inc (FIGS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,579,144 shares.
FIGS Inc (FIGS)'s detailed insider trading history can be found in Insider Trading Tracker table.
FIGS Inc Insider Transactions
- Download to Excel(.xls)
What does Frazier Lifesciences Acquisition Corp do?
Who are the key executives at Frazier Lifesciences Acquisition Corp?
Rose Sharon Shabet is the 10 percent owner of Frazier Lifesciences Acquisition Corp. Other key executives at Frazier Lifesciences Acquisition Corp include director & Chief Financial Officer David Joseph Topper , 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) , and 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. .
Frazier Lifesciences Acquisition Corp (FLAC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Frazier Lifesciences Acquisition Corp (FLAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Frazier Lifesciences Acquisition Corp (FLAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Frazier Lifesciences Acquisition Corp (FLAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Frazier Lifesciences Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does Frazier Lifesciences Acquisition Corp do?
Who are the key executives at Frazier Lifesciences Acquisition Corp?
Rose Sharon Shabet is the 10 percent owner of Frazier Lifesciences Acquisition Corp. Other key executives at Frazier Lifesciences Acquisition Corp include director & Chief Financial Officer David Joseph Topper , 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) , and 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. .
Frazier Lifesciences Acquisition Corp (FLACU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Frazier Lifesciences Acquisition Corp (FLACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Frazier Lifesciences Acquisition Corp (FLACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Frazier Lifesciences Acquisition Corp (FLACU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Frazier Lifesciences Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does RayzeBio inc do?
Who are the key executives at RayzeBio inc?
Rose Sharon Shabet is the 10 percent owner of RayzeBio inc. Other key executives at RayzeBio inc include 10 percent owner Viking Global Investors Lp , 10 percent owner Viking Global Opportunities Drawdown (aggregator) Lp , and 10 percent owner Goodman Corey S .
RayzeBio inc (RYZB) Insider Trades Summary
Over the past 18 months, Rose Sharon Shabet made no insider transaction in RayzeBio inc (RYZB). Other recent insider transactions involving RayzeBio inc (RYZB) include a net purchase of 2,777,778 shares made by Viking Global Investors Lp , and a net purchase of 472,222 shares made by Maha Katabi .
In summary, during the past 3 months, insiders sold 0 shares of RayzeBio inc (RYZB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of RayzeBio inc (RYZB) were sold and 3,250,000 shares were bought by its insiders, resulting in a net purchase of 3,250,000 shares.
RayzeBio inc (RYZB)'s detailed insider trading history can be found in Insider Trading Tracker table.
RayzeBio inc Insider Transactions
- Download to Excel(.xls)
Rose Sharon Shabet Mailing Address
Above is the net worth, insider trading, and ownership report for Rose Sharon Shabet. You might contact Rose Sharon Shabet via mailing address: 600 Washington Blvd., Floor 11, Stamford Ct 06901.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
